Lipid-lowering therapy can be considered with a 10-year PREVENT-ASCVD risk estimate of 3% to <5% (borderline) and should be considered for those at 5% to <10% (intermediate) 10-year risk. For ...
Abstract: Patients with severe Parkinson’s disease (PD) frequently have freezing of gait (FOG), a gait disability. By anticipating FOG before it occurs, pre-emptive cueing can either prevent FOG or ...
Abstract: Consumer-Centric Digital Twins (CCDT) are emerging as transformative enablers in Healthcare 5.0, offering real-time monitoring, predictive analytics, and patient-specific treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results